Italy is seeking 1.2 billion euros ($1.6 billion) in damages from Roche Holding AG and Novartis AG over allegations the two drugmakers colluded to direct patients with an eye disorder to a more expensive medicine.
Earl Harford, a retired professor, recently bought a month’s worth of the pills he needs to keep his leukemia at bay. The cost: $7,676, or three times more than when he first began taking the pills in 2001. Over the years, he has paid more than $140,000 from his retirement savings to cover his share of the drug’s price.
Novartis AG plans to close two sites in Europe, move staff from California to the Boston area and cut about 500 jobs in an effort consolidate its research operations, especially in respiratory diseases.